Showing results (191-200 of 538) with videos related to
Sort By:
Pageof 54
Frontiers in Immunology|March 14, 2022
Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.Joint Bone Spine|December 16, 2021
Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practiceMarie Pean de Ponfilly-Sotier, Florent L Besson, Léa Gomez, et al.Annals of the Rheumatic Diseases|September 3, 2011
Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysisXavier Mariette, Marco Matucci-Cerinic, Karel Pavelka, et al.Annals of the Rheumatic Diseases|December 23, 2006
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosusJérémie Sellam, Corinne Miceli-Richard, Jacques-Eric Gottenberg, et al.Annals of the Rheumatic Diseases|June 30, 2009
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Simon J Bowman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonatesKarim Fizazi, Allan Lipton, Xavier Mariette, et al.Plos One|May 10, 2014
Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohortKarine Chevreul, Georges Haour, Sandy Lucier, et al.RMD Open|March 1, 2017
Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective studyRieke Alten, Hubert G Nüßlein, Xavier Mariette, et al.The Journal of Infection|August 8, 2013
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter studyPierre Loulergue, Florence Tubach, Dominique Salmon, et al.Joint Bone Spine|April 6, 2025
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATEJacques Morel, Amélie Wetzman, Daniel Wendling, et al.Pageof 54